Analysis of the Persistence, Reservoir and HIV Latency
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Strasbourg, France
About this trial
The APRIL study aims at analyzing HIV reservoirs, latency and persistence on antiretroviral therapy. It enrolls HIV-infected adults providing blood samples of which peripheral blood mononuclear cells are stored. The frequency, phenotype and inducibility of HIV-infected cells are then analyzed. These parameters may vary across the different clinical and therapeutic settings.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
HIV-infection
Adults (>18 years)
Social insurance
Informed consent
Disqualifiers
HIV-uninfected
<18 years
Lack of social insurance
Lack or withdraw of consent
Trial population
HIV-infected adults
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
HIV-Flow
Time frame
1 dayLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: